|Day's Range||2.94 - 2.94|
|52 Week Range||0.58 - 3.00|
|PE Ratio (TTM)||40.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo FinanceGet free summary analysis HemaCare Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of HemaCare Corp. – Tivity Health, Inc. (TVTY-US) that have also reported for this period. Highlights Gross margins widened from 45.45% to 51.35% compared to the same period last year, ... Read more (Read more...)
HemaCare Corporation , a leader in cell and tissue collection, processing and cell therapy solutions, will be exhibiting at the annual meeting of the International Society of Cell Therapy in London, UK, May 3-6, 2017.
HemaCare Corporation , a leader in cell and tissue collection, processing and solutions for cell therapy, will be attending the AACR annual meeting at the Walter E. Washington Convention Center in Washington, D.C.